Stratipath Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
18
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$2.32M
- Investors
-
4
Stratipath General Information
Description
Developer of artificial intelligence-based precision diagnostics technology intended to improve cancer treatment decisions and patient outcomes. The company provides decision support tools to pathology labs and oncology clinics and identifies biomarker strategies to radically improve treatment decisions and outcomes in cancer care, enabling pharma and biotech companies to have fast, precise, and affordable technology for diagnosis, prognosis, and stratification of cancer patients along with cost-effective AI-based diagnosis.
Contact Information
Website
www.stratipath.comCorporate Office
- Nanna Svartz väg 4A
- 171 65 Solna
- Sweden
Corporate Office
- Nanna Svartz väg 4A
- 171 65 Solna
- Sweden
Stratipath Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC | 26-Jul-2021 | $2.32M | Completed | Generating Revenue | ||
| 2. Accelerator/Incubator | 01-May-2021 | Completed | Generating Revenue | |||
| 1. Grant | 01-Oct-2020 | $11.3K | Completed | Generating Revenue |
Stratipath Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary |
Stratipath Patents
Stratipath Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12536657-B2 | Texture metrics in cancer prognosis | Active | 12-Jun-2023 | ||
| US-20240412354-A1 | Texture metrics in cancer prognosis | Active | 12-Jun-2023 | ||
| EP-4409603-A1 | System for cancer progression risk determination | Pending | 28-Sep-2021 | ||
| US-12633417-B2 | System for cancer progression risk determination | Active | 28-Sep-2021 | ||
| US-20240331874-A1 | System for cancer progression risk determination | Active | 28-Sep-2021 | G16H50/30 |
Stratipath Signals
Stratipath Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Nascent Invest | Venture Capital | Minority | ||
| Angel (individual) | Minority | |||
| DRIVE (KI Innovations Business Incubator) | Accelerator/Incubator | |||
| Vinnova | Government |
Stratipath FAQs
-
When was Stratipath founded?
Stratipath was founded in 2019.
-
Where is Stratipath headquartered?
Stratipath is headquartered in Solna, Sweden.
-
What is the size of Stratipath?
Stratipath has 18 total employees.
-
What industry is Stratipath in?
Stratipath’s primary industry is Diagnostic Equipment.
-
Is Stratipath a private or public company?
Stratipath is a Private company.
-
What is the current valuation of Stratipath?
The current valuation of Stratipath is .
-
What is Stratipath’s current revenue?
The current revenue for Stratipath is .
-
How much funding has Stratipath raised over time?
Stratipath has raised $2.32M.
-
Who are Stratipath’s investors?
Nascent Invest, , DRIVE (KI Innovations Business Incubator), and Vinnova have invested in Stratipath.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process